Craft
Elanco

Elanco

Patents and Patent Applications

3 K

FY, 2019

Revenue

$4.8 B

FY, 2021

Market Capitalization

$6.9 B

2022-09-19

Elanco Summary

Company summary

Overview
Elanco Animal Health is a company that develops, manufactures, and markets products for animal health. It provides products and knowledge services to improve animal health and food-animal production. The company offers companion animal disease prevention products, such as parasiticide products, companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications, vaccines, nutritional enzymes, and animal-only antibiotics. It also delivers a range of food animal products used in ruminant and swine production.
Type
Public
Founded
1954
HQ
Greenfield, IN, US | view all locations
Website
https://www.elanco.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Jeffrey N. Simmons

    Jeffrey N. Simmons, President and CEO

  • Ramiro Cabral

    Ramiro Cabral, Executive Vice President, Elanco International

  • Jacques Zimmowitch

    Jacques Zimmowitch, Senior Vice President - Global Quality & EHS

  • Fadi Debes

    Fadi Debes, Senior Vice President, Corporate Controller and Financial Services

Operating MetricsView all

Patents and Patent Applications

3K

FY, 2019

Brands

125

FY, 2019

Countries

90

FY, 2019

LocationsView all

39 locations detected

  • Greenfield, IN HQ

    United States

    2500 Innovation Way

  • Manuel Alberti, Provincia de Buenos Aires

    Argentina

    Colectora Este Ramal Pilar

  • Macquarie Park, NSW

    Australia

    Level 1/3-7 Eden Park Dr

  • Wien, Wien

    Austria

    Gertrude-Fröhlich-Sandner-Straße 3

  • Antwerpen, Vlaanderen

    Belgium

    Plantin en Moretuslei 1a

  • Santo Antonio, SP

    Brazil

    Condominio Parque da Cidade Avenida das Nacoes Unidas 13th Floor

and 33 others

Elanco Financials

Summary financials

Revenue (Q2, 2022)
$1.2B
Gross profit (Q2, 2022)
$693.0M
Net income (Q2, 2022)
($22.0M)
Cash (Q2, 2022)
$507.0M
Enterprise value
$12.4B

Footer menu